RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
Results presented below are derived from data collected from over 475 news feeds.
Click on one of these terms to refine your search
1 to 10 of 408 stories
-
UNIGENE ANNOUNCES PROMISING PRECLINICAL RESULTS IN ITS OBESITY PEPTIDE PROGRAM
PR-inside.com. - December 17, 2009BOONTON, NJ December 17, 2009 -- Unigene Laboratories, Inc. (OTCBB: UGNE, http://www.unigene.com) announced today that it has selected a lead peptide compound, designated UGP281, from its obesity program for development. In a short-term study reported at the Keystone Symposium Confer…
-
Alethia Biotherapeutics Secures Diagnostic Rights to Peptide that Binds to Tumor-Associated Clusterin
Genetic Engineering & Biotechnology News. -
Peptide could be clue for cancer vax
FierceVaccines. - February 17, 2010In a recent study, 100 percent of mice vaccinated with a peptide remained tumor-free for at least 60 days after inoculation with colon cancer cells. And scientists from the University of Colorado School of Medicine and National Jewish Health say this method could be a key in developin…
-
Peptides potential for malaria medicines
Royal Society of Chemistry.Researchers from the UK have designed a test that will help in the search for new anti-malaria medicines
-
Powerful New Peptide Eye Repair Cream
PR-inside.com. - February 10, 2010Mad Hippie Skin Care (http://www.madhippie.com) out of Portland, Maine, is excited to announce the release of their new eye cream, no more crows. After the successful launch of their first product, repair butter face cream, Mad Hippie has been overwhelmed with the tremendously positiv…
-
Peptides - from Synthesis to Analysis
Bionity.COM. - January 11, 201002 Mar 2010 - 04 Mar 2010 Berlin, Darmstadt und Kamp-Lintfort, Germany CEM s microwave technology is changing the way scientists are performing peptide synthesis and sample preparation for proteomics applications and amino acid analysis. The low frequency energy of microwave irradiati…
-
Compugen to Screen Peptides for Pfizer
GenomeWeb. - December 23, 2009Pfizer will fund the drug target studies and will hold options for milestones and licensing.
-
Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor
nature. - November 08, 2008In HIV research, new types of reagents are needed to target infected cells and overcome HIV's ability to vary its HLA-I-restricted antigens and escape from host cytotoxic T lymphocytes. Here Varela-Rohena and colleagues use phage display technology to generate high-affinity T-cell ant…
-
Pretty peptide patterns
Royal Society of Chemistry.The smallest building blocks to date have been used to make fractal patterns
-
Prolor Biotech Takes Option to Peptide Rx Candidates from Weizmann's Yeda R&D
GenomeWeb. - August 05, 2009Prolor has the option to obtain from Yeda a license to develop a number of peptide drug candidates, including an anti-obesity peptide, using a delivery technology developed at the Weizmann Institute.
